相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
Lindsey M. Charo et al.
MOLECULAR ONCOLOGY (2021)
A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report
Yunke Huang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Lara Paracchini et al.
CLINICAL CANCER RESEARCH (2021)
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Du-Bois Asante et al.
CANCER LETTERS (2020)
Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer
Maria Rusan et al.
EUROPEAN JOURNAL OF CANCER (2020)
Circulating tumor DNA as an early cancer detection tool
Andrea Campos-Carrillo et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing
Marina Nemtsova et al.
SCIENTIFIC REPORTS (2020)
Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study
Mariana Cartaxo Alves et al.
TUMOR BIOLOGY (2020)
Biomarkers and Strategies for Early Detection of Ovarian Cancer
Robert C. Bast et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
A Study of hTERT Promoter Methylation in Circulating Tumour DNAs of Patients with Ovarian Magnificent Tumour
Songyi Li et al.
ONCOTARGETS AND THERAPY (2020)
Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact
Tomoko Noguchi et al.
CANCERS (2020)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis
Lei Zhang et al.
MOLECULAR CANCER (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G. Rothwell et al.
NATURE MEDICINE (2019)
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
Yuxuan Wang et al.
JAMA ONCOLOGY (2019)
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Kevin K. Lin et al.
CANCER DISCOVERY (2019)
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
N. Guibert et al.
ANNALS OF ONCOLOGY (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Lydia Giannopoulou et al.
GYNECOLOGIC ONCOLOGY (2018)
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Rebecca C. Arend et al.
MOLECULAR CANCER RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
S. Manier et al.
NATURE COMMUNICATIONS (2018)
PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
Asuka Morikawa et al.
Oncotarget (2018)
Next-generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug-resistant recurrent ovarian cancer
Zhen-Hua Du et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration
Makoto Nakabayashi et al.
SCIENTIFIC REPORTS (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer
Amy L. Wilson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
Elizabeth L. Christie et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Iron addiction: a novel therapeutic target in ovarian cancer
D. Basuli et al.
ONCOGENE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
Bi Wang et al.
ONCOLOGY LETTERS (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Olga Kondrashova et al.
CANCER DISCOVERY (2017)
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients
Ping-Ying Chang et al.
ONCOTARGET (2017)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter et al.
GENOME MEDICINE (2017)
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Peter McAnena et al.
CANCERS (2017)
Assessment of circulating copy number variant detection for cancer screening
Bhuvan Molparia et al.
PLOS ONE (2017)
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2017)
ReMixT: clone-specific genomic structure estimation in cancer
Andrew W. McPherson et al.
GENOME BIOLOGY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Circulating-tumor DNA as an early detection and diagnostic tool
Timothy M. Butler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
Gayatri Arun et al.
GENES & DEVELOPMENT (2016)
Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening
Paul A. Cohen et al.
BMC MEDICINE (2016)
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer Updated Guidelines From the European Group on Tumor Markers
Gyorgy Soletormos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
Umberto Malapelle et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Karen L. Reckamp et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine
Kimberly S. Butler et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
Faye R. Harris et al.
SCIENTIFIC REPORTS (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
Pamela J. Kaisaki et al.
PLOS ONE (2016)
Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas
Ryo Uratani et al.
PLOS ONE (2016)
Application of Multiplex Nested Methylated Specific PCR in Early Diagnosis of Epithelial Ovarian Cancer
Bi Wang et al.
Asian Pacific Journal of Cancer Prevention (2015)
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan et al.
CANCER CELL (2015)
Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq
Scott V. Bratman et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies
Diana W. Bianchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma
Jun Zhou et al.
ONCOLOGY REPORTS (2015)
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
Kun Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Exome Sequencing: Current and Future Perspectives
Amanda Warr et al.
G3-GENES GENOMES GENETICS (2015)
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Frederic Amant et al.
JAMA ONCOLOGY (2015)
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Elena Pereira et al.
PLOS ONE (2015)
Clinical and genetic predictors of prognosis in myelodysplastic syndromes
Rafael Bejar
HAEMATOLOGICA (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma
Daniel Klevebring et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA
John A. Martignetti et al.
NEOPLASIA (2014)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers
Isaac Kinde et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Ellen Heitzer et al.
GENOME MEDICINE (2013)
Characterizing and measuring bias in sequence data
Michael G. Ross et al.
GENOME BIOLOGY (2013)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
Immunohistochemical Localization of HE4 in Benign, Borderline, and Malignant Lesions of the Ovary
Penelope Georgakopoulos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
Thomas E. Liggett et al.
GYNECOLOGIC ONCOLOGY (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CA 125 and the Detection of Recurrent Ovarian Cancer
Robert C. Bast
CANCER (2010)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax
P. Bagan et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin
H Miyashita et al.
ORAL ONCOLOGY (2003)
分享论文
